ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $330,999 | -32.3% | 61,524 | -4.5% | 0.00% | – |
| Q2 2023 | $489,115 | -24.0% | 64,442 | +1.6% | 0.00% | – |
| Q4 2022 | $643,568 | -58.5% | 63,437 | -56.8% | 0.00% | -100.0% |
| Q3 2022 | $1,551,000 | -55.3% | 146,748 | -56.5% | 0.00% | -50.0% |
| Q2 2022 | $3,471,000 | -48.4% | 337,650 | -50.6% | 0.00% | -50.0% |
| Q1 2022 | $6,726,000 | +349.6% | 683,502 | +563.8% | 0.00% | +300.0% |
| Q4 2021 | $1,496,000 | -34.6% | 102,974 | -12.5% | 0.00% | 0.0% |
| Q3 2021 | $2,289,000 | +48.2% | 117,664 | +62.3% | 0.00% | 0.0% |
| Q2 2021 | $1,545,000 | -26.5% | 72,490 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $2,102,000 | +790.7% | 68,723 | +966.5% | 0.00% | – |
| Q4 2020 | $236,000 | – | 6,444 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |